Nymox Pharma (NYMX) puts active after reporting trial data

October 11, 2016 10:36 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Nymox Pharma (NASDAQ: NYMX) October 2.5 and November 1 puts are active on total put volume of 6,700 contracts (1,560 calls) after reporting new study results from Phase 3 trials for fexopotide. October put option implied volatility is at 245, November is at 250; compared to its 52-week range of 89 to 225.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment